Should Ambuja Cements Limited (NSE:AMBUJACEM) Be Your Next Stock Pick?

In this article:

Ambuja Cements Limited (NSE:AMBUJACEM) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of AMBUJACEM, it is a well-regarded dividend payer that has been able to sustain great financial health over the past. Below, I’ve touched on some key aspects you should know on a high level. If you’re interested in understanding beyond my high-level commentary, take a look at the report on Ambuja Cements here.

Flawless balance sheet average dividend payer

AMBUJACEM’s strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. This suggests prudent control over cash and cost by management, which is a key determinant of the company’s health. AMBUJACEM appears to have made good use of debt, producing operating cash levels of 114x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.

NSEI:AMBUJACEM Historical Debt October 18th 18
NSEI:AMBUJACEM Historical Debt October 18th 18

AMBUJACEM is also a dividend company, with ample net income to cover its dividend payout, which has been consistently growing over the past decade, keeping income investors happy.

NSEI:AMBUJACEM Historical Dividend Yield October 18th 18
NSEI:AMBUJACEM Historical Dividend Yield October 18th 18

Next Steps:

For Ambuja Cements, I’ve put together three relevant factors you should further examine:

  1. Future Outlook: What are well-informed industry analysts predicting for AMBUJACEM’s future growth? Take a look at our free research report of analyst consensus for AMBUJACEM’s outlook.

  2. Historical Performance: What has AMBUJACEM’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.

  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of AMBUJACEM? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Advertisement